A carregar...

Treatment compliance with first line disease-modifying therapies in patients with multiple sclerosis. COMPLIANCE Study

Introduction: Non-adherence to disease-modifying therapies (DMTs) in multiple sclerosis may be associated with reduced efficacy. We assessed compliance, the reasons for non-compliance, treatment satisfaction, and quality of life (QoL) of patients treated with first-line therapies. Methods: A cross-s...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: A. Saiz, S. Mora, J. Blanco
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier España 2015-05-01
Colecção:Neurología (English Edition)
Acesso em linha:http://www.sciencedirect.com/science/article/pii/S2173580815000346
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!